NBHC:NYSENational Bank Holdings Corporation Analysis
Data as of 2026-05-21 - not real-time
$42.04
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
National Bank Holdings is trading at $42.04, just above its 50‑day SMA ($40.83) and below the 20‑day SMA ($42.24), indicating a modest bullish bias despite a bearish MACD histogram. The stock sits comfortably above the identified support at $40.66 and below the 52‑week high resistance of $43.86, with the RSI at 52.7% suggesting no immediate overbought pressure. Fundamentally, revenue surged 33.7% YoY to $429 M and profit margins hover around 25%, while the forward PE of 10.2 signals attractive earnings growth potential.
The dividend yield of 3.04% and a payout ratio under 46% point to a sustainable income stream, and the DCF‑derived fair value of $42.22 plus analyst targets averaging $48 imply roughly 14% upside. Combined with a beta near 1.0, 30‑day volatility of 22.7%, and an “Extreme Greed” market sentiment, the risk‑adjusted profile remains moderate, supporting a positive outlook across horizons.
The dividend yield of 3.04% and a payout ratio under 46% point to a sustainable income stream, and the DCF‑derived fair value of $42.22 plus analyst targets averaging $48 imply roughly 14% upside. Combined with a beta near 1.0, 30‑day volatility of 22.7%, and an “Extreme Greed” market sentiment, the risk‑adjusted profile remains moderate, supporting a positive outlook across horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term support with decreasing volume
- Bearish MACD histogram despite overall bullish trend
- Neutral RSI indicating limited near‑term momentum
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 33.7% revenue growth and strong profit margins
- Dividend yield of 3.04% with sustainable payout ratio
- Valuation upside of ~14% versus analyst target price
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Stable balance sheet with cash exceeding debt
- Consistent dividend and low debt‑to‑equity profile
- Favorable forward PE and industry‑relative valuation
Key Metrics & Analysis
Financial Health
Revenue Growth33.70%
Profit Margin24.73%
P/E Ratio15.7
ROE7.09%
ROA0.94%
P/B Ratio1.1
Op. Cash Flow$66.0M
Industry P/E16.7
Technical Analysis
TrendBullish
RSI52.7
Support$40.66
Resistance$43.86
MA 20$42.24
MA 50$40.83
MA 200$39.31
MACDBearish
VolumeDecreasing
Fear & Greed Index90.73
Valuation
Fair Value$42.22
Target Price$48.25
Upside/Downside14.77%
GradeUndervalued
TypeBlend
Dividend Yield3.04%
Risk Assessment
Beta0.96
Volatility22.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.